The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMC 2180975)

Published in J Exp Med on November 01, 1977

Authors

P Teisberg, B Olaisen, R Jonassen, T Gedde-Dahl, E Thorsby

Articles cited by this

Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med (1972) 5.61

Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med (1974) 3.38

Genetic polymorphism of the third component of human complement (C'3). J Clin Invest (1968) 3.10

Fourth component of human complement: description of a three polypeptide chain structure. J Exp Med (1974) 2.93

Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J Exp Med (1976) 2.89

High voltage agarose gel electrophoresis in the study of C 3 polymorphism. Vox Sang (1970) 2.43

Linkage of HL-A and GBG. Vox Sang (1974) 2.23

Structural polymorphism of the fourth component of human complement. J Clin Invest (1969) 1.91

Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82

Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55

Properdin factor B and histocompatibility loci linked in the rhesus monkey. Nature (1975) 1.27

Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27

Allotypes of complement components in man. Transplant Rev (1976) 1.27

The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik (1975) 1.07

C3 polymorphism: genetic linkage relations. Clin Genet (1974) 1.00

Electrophoretic polymorphism of the fourth component of human complement (C4) in paired maternal and foetal plasmas. Immunology (1971) 0.92

The localization of the Bf locus within the MHS region on chromosome no. 6. Tissue Antigens (1976) 0.90

Nonlinkage between C6 and chromosome 6 markers. Hum Genet (1977) 0.90

Bf maps between the HLA--A and D loci. Tissue Antigens (1976) 0.89

On the localization of the Gb locus within the MHS region of chromosome No. 6. Tissue Antigens (1975) 0.85

Localization of the Bf locus within the HLA region. Report on an informative family and critical evaluation of available data on Bf mapping. Hum Genet (1976) 0.81

Articles by these authors

Report of the Committee on the Genetic Constitution of Chromosomes 13, 14, 15 and 16. Cytogenet Cell Genet (1985) 6.87

International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet (1988) 4.84

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30

Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet (2001) 3.50

Autosomal linkage between the Gm and Pi loci in man. Ann Hum Genet (1972) 3.34

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10

Genes and languages in Europe: an analysis of mitochondrial lineages. Genome Res (1995) 2.93

HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72

HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70

Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66

HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58

Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A (1985) 2.44

High voltage agarose gel electrophoresis in the study of C 3 polymorphism. Vox Sang (1970) 2.43

DNA recommendations. Further report of the DNA Commission of the ISFH regarding the use of short tandem repeat systems. International Society for Forensic Haemogenetics. Int J Legal Med (1997) 2.35

The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17

Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09

[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02

HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97

Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85

Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85

Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet (2002) 1.84

Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77

HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67

Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66

Y-chromosomal microsatellite mutation rates: differences in mutation rate between and within loci. Hum Mutat (2004) 1.60

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53

HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53

T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52

Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51

The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50

Report of the Committee on the Genetic Constitution of Chromosomes 5 and 6. Cytogenet Cell Genet (1985) 1.47

Paternity Testing Commission of the International Society of Forensic Genetics. Recommendations on genetic investigations in paternity cases. Int J Legal Med (2003) 1.46

CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45

Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43

Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43

HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42

The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum Genet (1982) 1.40

[Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors]. Tidsskr Nor Laegeforen (1999) 1.39

Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38

DNA commission of the international society for forensic genetics: guidelines for mitochondrial DNA typing. Forensic Sci Int (2000) 1.37

T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35

Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33

In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32

Report of the committee on the genetic constitution of chromosomes 13, 14, 15 amd 16. Cytogenet Cell Genet (1987) 1.32

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32

Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32

Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32

Humoral immune system activity in inflammatory bowel disease. Scand J Gastroenterol (1975) 1.31

On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31

The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30

Very close linkage between HLA-B and Bf inferred from allelic association. Nature (1977) 1.30

DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28

Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27

Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol (1995) 1.27

The human major histocompatibility system. Transplant Rev (1974) 1.25

Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24

A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22

HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22

HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22

Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system. Clin Exp Immunol (1973) 1.22

Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22

The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21

Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19

Cell specific and common antigens on human granulocytes and lymphocytes demonstrated with cytotoxic hetero-antibodies. Vox Sang (1967) 1.19

The C8A and C8B loci are closely linked on chromosome 1. Ann Hum Genet (1986) 1.19

Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19

DNA Commission of the International Society for Forensic Genetics: guidelines for mitochondrial DNA typing. Int J Legal Med (2000) 1.18

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17

HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17

Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17

Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. Transplant Proc (1979) 1.17

Sixteen types of epidermolysis bullosa. On the clinical discrimination, therapy and prenatal diagnosis. Acta Derm Venereol Suppl (Stockh) (1981) 1.16

Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16

Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15

HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14

Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis. J Med Genet (2007) 1.13

Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin. Hum Hered (1969) 1.12

Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12

Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11

Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11

Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13. J Med Genet (2004) 1.10

Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. J Immunol Methods (1977) 1.10

Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol (1981) 1.10

T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1989) 1.09

Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venereol (1980) 1.09